Sign in
4

Changes in Ownership

Entrada Therapeutics, Inc. Filed Acc 0001104659-22-030002

President and CEO acquired 30,250 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Doshi Dipal President and CEO 2022-03-01 Grant or award +30,250 214,710 D: show line 1 in the form

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
Doshi Dipal President and CEO 2022-03-01 Grant or award · Stock Option (Right to Buy) +181,500 181,500 D: show line 2 in the form
Loading xslF345X03/tm228284d1_4seq1.xml…